PNA-MYCN treatment in pediatric T-ALL samples reduced cell viability of leukemic cells from patients with high MYCN expression, while no effect was obtained in MYCN-negative blast cells. This evidence concerns the gene MYCN and acute lymphoblastic leukemia.